Outcomes for Children With Pulmonary Hypertension Undergoing Tracheostomy Placement: A Multi-Institutional Analysis

Pediatr Crit Care Med. 2022 Sep 1;23(9):717-726. doi: 10.1097/PCC.0000000000003002. Epub 2022 Jun 10.

Abstract

Objectives: To describe epidemiology, interventions, outcomes, and the health services experience for a cohort of children with pulmonary hypertension (PH) who underwent tracheostomy placement and to identify risk factors for inhospital mortality and 30-day readmissions.

Design: Retrospective cohort study of the Pediatric Health Information System database.

Setting: Thirty-seven freestanding U.S. children's hospitals.

Patients: Patients 31 days to 21 years old who were discharged from the hospital between January 1, 2009, and December 31, 2017, with a diagnosis of primary or secondary PH, and who underwent tracheostomy placement. Outcomes were examined over a 2-year period from the time of discharge from the index encounter.

Interventions: None.

Measurements and main results: There were 793 patients with PH who underwent tracheostomy placement. The overall inhospital mortality rate was 23.7%. Secondary PH due to congenital heart disease (CHD) was significantly associated with overall inhospital mortality (adjusted odds ratio [OR], 2.36; 95% CI, 1.38-4.04). The rate of 30-day readmissions for patients over the 2-year follow-up period was 33.3%. Tracheostomy during the index encounter and the diagnosis of secondary PH due to CHD were significantly associated with lower rates of 30-day readmissions (adjusted OR, 0.34; 95% CI, 0.19-0.61; and adjusted OR, 0.43; 95% CI, 0.24-0.77, respectively).

Conclusions: In the context of expanding utilization of tracheostomy and long-term ventilation, children with PH are among the highest risk cohorts for extended and repeated hospitalization and death. Tracheostomy placement during the index encounter was associated with fewer 30-day readmissions over the 2-year follow-up period. Further understanding of which subgroups may benefit from earlier intervention and which subgroups are at highest risk may offer important clinical insight when considering optimal timing of tracheostomy and may enhance informed decision-making for all stakeholders.

Publication types

  • Multicenter Study

MeSH terms

  • Child
  • Heart Defects, Congenital* / surgery
  • Hospital Mortality
  • Humans
  • Hypertension, Pulmonary* / etiology
  • Hypertension, Pulmonary* / surgery
  • Patient Readmission
  • Retrospective Studies
  • Tracheostomy